Literature DB >> 22110002

Altered neural activation in ornithine transcarbamylase deficiency during executive cognition: an fMRI study.

Andrea L Gropman1, Kyle Shattuck, Morgan J Prust, Rebecca R Seltzer, Andrew L Breeden, Ayichew Hailu, Amanda Rigas, Rehan Hussain, John VanMeter.   

Abstract

BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) is an X-linked urea cycle disorder characterized by hyperammonemia resulting in white matter injury and impairments in working memory and executive cognition.
OBJECTIVE: To test for differences in BOLD signal activation between subjects with OTCD and healthy controls during a working memory task. DESIGN, SETTING AND PATIENTS: Nineteen subjects with OTCD and 21 healthy controls participated in a case-control, IRB-approved study at Georgetown University Medical Center. INTERVENTION: An N-back working memory task was performed in a block design using 3T functional magnetic resonance imaging.
RESULTS: In subjects with OTCD we observed increased BOLD signal in the right dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) relative to healthy age matched controls.
CONCLUSIONS: Increased neuronal activation in OTCD subjects despite equivalent task performance points to sub-optimal activation of the working memory network in these subjects, most likely reflecting damage caused by hyperammonemic events. These increases directly relate to our previous finding of reduced frontal white matter integrity in the superior extents of the corpus callosum; key hemispheric connections for these areas. Future studies using higher cognitive load are required to further characterize these effects.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22110002      PMCID: PMC3338900          DOI: 10.1002/hbm.21470

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  24 in total

Review 1.  Working memory: looking back and looking forward.

Authors:  Alan Baddeley
Journal:  Nat Rev Neurosci       Date:  2003-10       Impact factor: 34.870

Review 2.  Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging.

Authors:  Mark D'Esposito; Leon Y Deouell; Adam Gazzaley
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

3.  Anterior cingulate conflict monitoring and adjustments in control.

Authors:  John G Kerns; Jonathan D Cohen; Angus W MacDonald; Raymond Y Cho; V Andrew Stenger; Cameron S Carter
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

4.  Diffusion tensor imaging detects areas of abnormal white matter microstructure in patients with partial ornithine transcarbamylase deficiency.

Authors:  A L Gropman; B Gertz; K Shattuck; I L Kahn; R Seltzer; L Krivitsky; J Van Meter
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-20       Impact factor: 3.825

5.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

Authors:  J H Callicott; A Bertolino; V S Mattay; F J Langheim; J Duyn; R Coppola; T E Goldberg; D R Weinberger
Journal:  Cereb Cortex       Date:  2000-11       Impact factor: 5.357

6.  Ammonium-induced impairment of axonal growth is prevented through glial creatine.

Authors:  Olivier Braissant; Hugues Henry; Anne-Marie Villard; Marie-Gabrielle Zurich; Marc Loup; Barbara Eilers; Gianni Parlascino; Edouard Matter; Olivier Boulat; Paul Honegger; Claude Bachmann
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

7.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 8.  Ammonia toxicity to the brain and creatine.

Authors:  Claude Bachmann; Olivier Braissant; Anne-Marie Villard; Olivier Boulat; Hugues Henry
Journal:  Mol Genet Metab       Date:  2004-04       Impact factor: 4.797

9.  Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down.

Authors:  Joseph H Callicott; Venkata S Mattay; Beth A Verchinski; Stefano Marenco; Michael F Egan; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

10.  Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency.

Authors:  Kunsang Gyato; J Wray; Z J Huang; M Yudkoff; Mark L Batshaw
Journal:  Ann Neurol       Date:  2004-01       Impact factor: 10.422

View more
  14 in total

1.  Undiagnosed Partial Ornithine Transcarbamylase Deficiency Presenting Postoperatively as Agitated Delirium.

Authors:  E D Goldstein; R Cannistraro; P S Atwal; J F Meschia
Journal:  Neurohospitalist       Date:  2017-09-12

Review 2.  Advances in urea cycle neuroimaging: Proceedings from the 4th International Symposium on urea cycle disorders, Barcelona, Spain, September 2013.

Authors:  Ileana Pacheco-Colón; Stanley Fricke; John VanMeter; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2014-05-20       Impact factor: 4.797

3.  Urea cycle defects and hyperammonemia: effects on functional imaging.

Authors:  Andrea L Gropman; Morgan Prust; Andrew Breeden; Stanley Fricke; John VanMeter
Journal:  Metab Brain Dis       Date:  2012-11-13       Impact factor: 3.584

Review 4.  Fifteen years of urea cycle disorders brain research: Looking back, looking forward.

Authors:  Kuntal Sen; Matthew Whitehead; Carlos Castillo Pinto; Ljubica Caldovic; Andrea Gropman
Journal:  Anal Biochem       Date:  2021-10-09       Impact factor: 3.365

5.  In human brain ornithine transcarbamylase (OTC) immunoreactivity is strongly expressed in a small number of nitrergic neurons.

Authors:  Hans-Gert Bernstein; Hendrik Dobrowolny; Gerburg Keilhoff; Johann Steiner
Journal:  Metab Brain Dis       Date:  2017-09-03       Impact factor: 3.584

6.  Investigating neurological deficits in carriers and affected patients with ornithine transcarbamylase deficiency.

Authors:  Courtney Sprouse; Jessica King; Guy Helman; Ileana Pacheco-Colón; Kyle Shattuck; Andrew Breeden; Rebecca Seltzer; John W VanMeter; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2014-05-20       Impact factor: 4.797

7.  Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.

Authors:  Susan E Waisbren; Andrea L Gropman; Mark L Batshaw
Journal:  J Inherit Metab Dis       Date:  2016-05-23       Impact factor: 4.982

Review 8.  Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue.

Authors:  Kuntal Sen; Afrouz A Anderson; Matthew T Whitehead; Andrea L Gropman
Journal:  Front Neurol       Date:  2021-04-28       Impact factor: 4.086

9.  Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism.

Authors:  Andrea L Gropman; Afrouz Anderson
Journal:  J Transl Genet Genom       Date:  2020-11-13

10.  Evaluation of neurocognitive function of prefrontal cortex in ornithine transcarbamylase deficiency.

Authors:  Afrouz Anderson; Andrea Gropman; Cynthia Le Mons; Constantine Stratakis; Amir Gandjbakhche
Journal:  Mol Genet Metab       Date:  2020-01-10       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.